Tenvie Therapeutics Revenue and Competitors
Employee Data
- Tenvie Therapeutics has 26 Employees.
- Tenvie Therapeutics grew their employee count by 189% last year.
Tenvie Therapeutics's People
| Name | Title | Email/Phone |
|---|
Tenvie Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 8 | 0% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 17 | 31% | N/A | N/A |
What Is Tenvie Therapeutics?
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
keywords:N/A
N/A
Total Funding
26
Number of Employees
N/A
Revenue (est)
189%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.7M | 26 | -10% | N/A |
#2 | $10.9M | 26 | -42% | $499M |
#3 | $26.8M | 26 | -54% | $130M |
#4 | $4.2M | 27 | -31% | N/A |
#5 | $3.1M | 29 | 81% | $42M |